BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 37288545)

  • 1. Using gut microbiota as a diagnostic tool for colorectal cancer: machine learning techniques reveal promising results.
    Lu F; Lei T; Zhou J; Liang H; Cui P; Zuo T; Ye L; Chen H; Huang J
    J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37288545
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of KRAS mutation-associated gut microbiota in colorectal cancer and construction of predictive machine learning model.
    Huang Z; Huang X; Huang Y; Liang K; Chen L; Zhong C; Chen Y; Chen C; Wang Z; He F; Qin M; Long C; Tang B; Huang Y; Wu Y; Mo X; Weizhong T; Liu J
    Microbiol Spectr; 2024 May; 12(5):e0272023. PubMed ID: 38572984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic evaluation of supervised classifiers for fecal microbiota-based prediction of colorectal cancer.
    Ai L; Tian H; Chen Z; Chen H; Xu J; Fang JY
    Oncotarget; 2017 Feb; 8(6):9546-9556. PubMed ID: 28061434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction model of poorly differentiated colorectal cancer (CRC) based on gut bacteria.
    Qi Z; Zhibo Z; Jing Z; Zhanbo Q; Shugao H; Weili J; Jiang L; Shuwen H
    BMC Microbiol; 2022 Dec; 22(1):312. PubMed ID: 36539710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of gut microbiota with leukopenia after chemotherapy in patients with colorectal cancer.
    Xiaofeng N; Jian C; Jingjing W; Zhanbo Q; Yifei S; Jing Z; Shuwen H
    BMC Microbiol; 2023 Nov; 23(1):349. PubMed ID: 37978347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers.
    Wang T; Cai G; Qiu Y; Fei N; Zhang M; Pang X; Jia W; Cai S; Zhao L
    ISME J; 2012 Feb; 6(2):320-9. PubMed ID: 21850056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiple-dimension model for microbiota of patients with colorectal cancer from normal participants and other intestinal disorders.
    Shen J; Jin G; Zhang Z; Zhang J; Sun Y; Xie X; Ma T; Zhu Y; Du Y; Niu Y; Shi X
    Appl Microbiol Biotechnol; 2022 Mar; 106(5-6):2161-2173. PubMed ID: 35218389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
    Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
    Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
    [No Abstract]   [Full Text] [Related]  

  • 9. Enterotype-based Analysis of Gut Microbiota along the Conventional Adenoma-Carcinoma Colorectal Cancer Pathway.
    Yang TW; Lee WH; Tu SJ; Huang WC; Chen HM; Sun TH; Tsai MC; Wang CC; Chen HY; Huang CC; Shiu BH; Yang TL; Huang HT; Chou YP; Chou CH; Huang YR; Sun YR; Liang C; Lin FM; Ho SY; Chen WL; Yang SF; Ueng KC; Huang HD; Huang CN; Jong YJ; Lin CC
    Sci Rep; 2019 Jul; 9(1):10923. PubMed ID: 31358825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF
    Trivieri N; Pracella R; Cariglia MG; Panebianco C; Parrella P; Visioli A; Giani F; Soriano AA; Barile C; Canistro G; Latiano TP; Dimitri L; Bazzocchi F; Cassano D; Vescovi AL; Pazienza V; Binda E
    J Exp Clin Cancer Res; 2020 Dec; 39(1):285. PubMed ID: 33317591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a colorectal cancer screening method using machine learning-based gut microbiota analysis.
    Konishi Y; Okumura S; Matsumoto T; Itatani Y; Nishiyama T; Okazaki Y; Shibutani M; Ohtani N; Nagahara H; Obama K; Ohira M; Sakai Y; Nagayama S; Hara E
    Cancer Med; 2022 Aug; 11(16):3194-3206. PubMed ID: 35318827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of intestinal microbiome associated with lymph-vascular invasion in colorectal cancer patients and predictive label construction.
    Chen C; Chen K; Huang Z; Huang X; Wang Z; He F; Qin M; Long C; Tang B; Mo X; Liu J; Tang W
    Front Cell Infect Microbiol; 2023; 13():1098310. PubMed ID: 37249979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota landscape and potential biomarker identification in female patients with systemic lupus erythematosus using machine learning.
    Song W; Wu F; Yan Y; Li Y; Wang Q; Hu X; Li Y
    Front Cell Infect Microbiol; 2023; 13():1289124. PubMed ID: 38169617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a colorectal cancer diagnostic model and dietary risk assessment through gut microbiome analysis.
    Yang J; McDowell A; Kim EK; Seo H; Lee WH; Moon CM; Kym SM; Lee DH; Park YS; Jee YK; Kim YK
    Exp Mol Med; 2019 Oct; 51(10):1-15. PubMed ID: 31582724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
    Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma.
    Zhang W; Xu X; Cai L; Cai X
    Sci Rep; 2023 May; 13(1):7797. PubMed ID: 37179446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer.
    Shah MS; DeSantis TZ; Weinmaier T; McMurdie PJ; Cope JL; Altrichter A; Yamal JM; Hollister EB
    Gut; 2018 May; 67(5):882-891. PubMed ID: 28341746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered intestinal microbiota associated with colorectal cancer.
    Zhang H; Chang Y; Zheng Q; Zhang R; Hu C; Jia W
    Front Med; 2019 Aug; 13(4):461-470. PubMed ID: 31250341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
    Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer: The combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer.
    Tang Q; Cang S; Jiao J; Rong W; Xu H; Bi K; Li Q; Liu R
    J Chromatogr A; 2020 Oct; 1629():461503. PubMed ID: 32858455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.